Stat Archives

Biotech Matthew Herper and Megan Molteni

Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

Health Tech Katie Palmer

Under new ownership, IBM Watson Health’s core assets get a rebranding

Health Tech Mohana Ravindranath and Katie Palmer

The Q3 health tech tracker: 11 key industry events and debates to watch

Biotech Matthew Herper

New analysis of Amarin’s Vascepa resurrects big questions about effectiveness

Health Tech Mario Aguilar

Cognito Therapeutics raises $50 million for Alzheimer’s treatment tech

A STAT Investigation Katie Palmer

Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

Health Tech Edward Chen

Smartphone apps promised to help combat the pandemic. How well did they work?

Special Report Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup

Facebook is receiving sensitive medical information from hospital websites

Health Tech Jonathan Wosen

Verily co-founder lays out vision for how real-world data can transform health care

Health Tech Mohana Ravindranath

With Cerner deal closed, Oracle chair pitches sweeping vision for health records and artificial intelligence

Health Tech Mohana Ravindranath

The graveyard of health tech pilots: why some experiments flourish and others fizzle

Health Tech Katie Palmer

With new research, health tech companies try to make a case for virtual diabetes care

Health Tech Mohana Ravindranath

Carbon Health, citing concerns about path to profitability, lays off 250 employees

Biotech Angus Chen

Companies can’t make CAR-T cells for cancer treatment quickly enough. Here’s what they’re doing about it

Health Tech Andrew Joseph

‘We have to test’: A Google AI leader on why it’s imperative to move slow in health tech

A STAT Investigation Casey Ross

How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

Pharmalot Ed Silverman

High blood pressure pills are costly — but also hard to find — in some lower-income countries

Health Tech Casey Ross

Stat

Most Read

The sale of Watson Health assets ends a dark chapter for IBM. For its buyer, the opportunity looks brighter

Clinical validation will save digital health’s reputation

One Medical’s dueling offers from Amazon and CVS signal a start to health tech bidding wars

Top IQVIA lawyer declines to discuss Experian relationship, but pledges Americans’ medical secrets are safe

A troubling report on Cerner’s VA rollout offers a rare look into the hidden harms of health records

Amazon has big ambitions in primary care. One Medical is just the latest piece of its plan

5 burning questions about Amazon’s $3.9 billion acquisition of One Medical

Researchers tried to calculate the impact of health tech companies. It sent startups into a tizzy

All Coverage

Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

Under new ownership, IBM Watson Health’s core assets get a rebranding

The Q3 health tech tracker: 11 key industry events and debates to watch

New analysis of Amarin’s Vascepa resurrects big questions about effectiveness

Cognito Therapeutics raises $50 million for Alzheimer’s treatment tech

Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

Smartphone apps promised to help combat the pandemic. How well did they work?

Facebook is receiving sensitive medical information from hospital websites

Verily co-founder lays out vision for how real-world data can transform health care

With Cerner deal closed, Oracle chair pitches sweeping vision for health records and artificial intelligence

The graveyard of health tech pilots: why some experiments flourish and others fizzle

With new research, health tech companies try to make a case for virtual diabetes care

Carbon Health, citing concerns about path to profitability, lays off 250 employees

Companies can’t make CAR-T cells for cancer treatment quickly enough. Here’s what they’re doing about it

‘We have to test’: A Google AI leader on why it’s imperative to move slow in health tech

How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

High blood pressure pills are costly — but also hard to find — in some lower-income countries

Google taps FDA’s former digital health chief for global strategy role

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day